Patents by Inventor Paul K. WOTTON

Paul K. WOTTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20240091239
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 21, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Administration of testosterone compositions
    Patent number: 11844804
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: December 19, 2023
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20230390187
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 11771646
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: October 3, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Hazardous Agent Injection System
    Publication number: 20230104341
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: October 5, 2022
    Publication date: April 6, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hazardous agent injection system
    Patent number: 11497753
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: November 15, 2022
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hematocrit Modulation Through Needle Assisted Jet Injection of Testosterone
    Publication number: 20220125713
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted injection device.
    Type: Application
    Filed: November 1, 2021
    Publication date: April 28, 2022
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Jonathan Jaffe
  • Hematocrit modulation through needle assisted jet injection of testosterone
    Patent number: 11160751
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: November 2, 2021
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Jonathan Jaffe
  • Administration of Testosterone Compositions
    Publication number: 20210137944
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Needle assisted injection administration of testosterone compositions
    Patent number: 10912782
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: February 9, 2021
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20210015741
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 2, 2020
    Publication date: January 21, 2021
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 10821072
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: November 3, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Prefilled syringes and kits thereof
    Patent number: 10675400
    Abstract: The present disclosure relates, in part, to a kit including at least two prefilled syringes. The first prefilled syringe includes a dose of a hazardous agent in a first volume of a pharmaceutical composition comprising a pharmaceutically acceptable solvent.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: June 9, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, Kaushik J. Dave, Dominic P. Capone
  • Hazardous Agent Injection System
    Publication number: 20200163975
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: December 16, 2019
    Publication date: May 28, 2020
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • Hazardous agent injection system
    Patent number: 10555954
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: February 11, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20190224215
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: February 1, 2019
    Publication date: July 25, 2019
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 10238662
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: March 26, 2019
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jon Jaffe
  • NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS
    Publication number: 20190030260
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Needle assisted jet injection administration of testosterone compositions
    Patent number: 9950125
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: April 24, 2018
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Hazardous Agent Injection System
    Publication number: 20170361021
    Abstract: Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
    Type: Application
    Filed: September 1, 2017
    Publication date: December 21, 2017
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Peter L. Sadowski, John W. Hayes